Terms: = Lung cancer AND RPL22, EAP, 6146 AND Prognosis
3 results:
1. Bioinformatics Identification of Key Genes for the Development and prognosis of lung Adenocarcinoma.
Luo X; Xu JG; Wang Z; Wang X; Zhu Q; Zhao J; Bian L
Inquiry; 2022; 59():469580221096259. PubMed ID: 35635202
[TBL] [Abstract] [Full Text] [Related]
2. Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Crinò L; Bronte G; Bidoli P; Cravero P; Minenza E; Cortesi E; Garassino MC; Proto C; Cappuzzo F; Grossi F; Tonini G; Sarobba MG; Pinotti G; Numico G; Samaritani R; Ciuffreda L; Frassoldati A; Bregni M; Santo A; Piantedosi F; Illiano A; De Marinis F; Tamberi S; Giannarelli D; Delmonte A
Lung Cancer; 2019 Mar; 129():35-40. PubMed ID: 30797489
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.
Mu XL; Li LY; Zhang XT; Wang SL; Wang MZ
BMC Cancer; 2004 Aug; 4():51. PubMed ID: 15318946
[TBL] [Abstract] [Full Text] [Related]
